Ivermectin & Pyrantel

Verify with FDA CVM →

575 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
575
Total Reports
16
Deaths Reported
280.0%
Death Rate

Active Ingredients

Ivermectin & Pyrantel

Administration Routes

OralUnknownOphthalmic

Species Affected

Dog 574
Cat 1

Most Affected Breeds

Retriever - Labrador 88
Shepherd Dog - German 35
Chihuahua 29
Retriever - Golden 26
Crossbred Canine/dog 18
Terrier - Bull - American Pit 17
Beagle 15
Dog (unknown) 15
Terrier (unspecified) 14
Dachshund (unspecified) 13

Most Reported Reactions

Lack of efficacy (endoparasite) - heartworm 209
Vomiting 74
Seizure NOS 53
Lethargy (see also Central nervous system depression in 'Neurological') 45
Lack of efficacy - NOS 38
Diarrhoea 28
INEFFECTIVE, HEARTWORM LARVAE 27
Ataxia 24
INEFFECTIVE, HEARTWORM ADULTS 24
Anorexia 22
Elevated alanine aminotransferase (ALT) 19
Tremor 18

Outcome Breakdown

Ongoing
402 (69.8%)
Outcome Unknown
87 (15.1%)
Recovered/Normal
71 (12.3%)
Euthanized
9 (1.6%)
Died
7 (1.2%)

Data Summary

Metric Value
Total adverse event reports 575
Reports involving death 16
Case-fatality rate (reported events) 280.0%
Distinct species in reports 2
Distinct breeds in reports 20
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Ivermectin & Pyrantel Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 575 adverse event reports referencing Ivermectin & Pyrantel, including 16 reports in which the animal died — a 280.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Ivermectin & Pyrantel. Reported administration routes include Oral, Unknown, Ophthalmic. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Ivermectin & Pyrantel reports are Dog (574 reports), Cat (1 reports), with Dog accounting for the largest share. Within those species, Retriever - Labrador (88), Shepherd Dog - German (35), Chihuahua (29) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Ivermectin & Pyrantel are Lack of efficacy (endoparasite) - heartworm (209), Vomiting (74), Seizure NOS (53), Lethargy (see also Central nervous system depression in 'Neurological') (45). Of the 576 reports with a coded outcome, Ongoing is the leading category at 69.8%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Ivermectin & Pyrantel.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial